Thibaud Damy

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis”.

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

New England Journal of Medicine(2023)10.1056/nejmoa2300757

N/A

5.3DataRank · unranked

317 citations

Parag Kale, Marianna Fontana, John L. Berk, Martha Grogan, Finn Gustafsson +32 more

Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy

JACC Heart Failure(2020)10.1016/j.jchf.2020.09.011

N/A

4.9DataRank · unranked

119 citations

Perry Elliott, Thibaud Damy, José Nativi-Nicolau, John L. Berk, Eric J. Velazquez +7 more

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases

European Heart Journal(2021)10.1093/eurheartj/ehab072

N/A

0DataRank · unranked

1164 citations

Claudio Rapezzi, Yehuda Adler, Michael Arad, Cristina Basso, Antonio Brucato +19 more

ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable

Orphanet Journal of Rare Diseases(2021)10.1186/s13023-021-01834-0

N/A

0DataRank · unranked

16 citations

Michaela Auer‐Grumbach, John L. Berk, Chiara Briani, Vera Bril, Teresa Coelho +22 more